id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dhrp-76	Espinoza, Ivan; Xiomara Rodriguez; Orfelinda Lopez; Daryl Trejo; Lluvia Villa; Melanie Cruz; San Juanita Gonzalez; Luis Salazar; Angelica Gonzalez; Anahi De Leon; Anahi Ybarra; Alondra Martinez	Epidemiology and Other Factors Affecting Weight Loss in Hispanics	2023	6	.pdf	application/pdf	3331	183	53	the Semaglutide (Ozempic) is an effective FDA-approved drug for chronic weight management in adults with obesity or over-weight.18 However, there are concerns about its cost, access, and affordability, particularly in underserved and underrepresented communities, such as the Hispanic community.18 In this study, researchers found that 57.1% of Semaglutide-eligible adults who had attempted to lose weight in the past 12 months were Hispanics.18 Cohen, and Gadde, researched other drugs that can help with weight loss therapy that have been approved in the United States are known as orlistat, lorcaserin, liraglutide, phentermine or topiramate, and naltrexone/bupropion.19 Ongoing stigma plays a huge role as to why many individuals do not seek the medical attention needed when they are stressed and overwhelmed which can also lead to weight loss.	cache/dhrp-76.pdf	txt/dhrp-76.txt
